[EXECUTION VERSION Second Supplemental Indenture Company Trustee This SECOND SUPPLEMENTAL INDENTURE (this RECITALS Base Indenture WHEREAS, the Company and the Trustee have heretofore executed and delivered an indenture, dated as of October 10, 2017 (the WHEREAS, Sections 2.1, 3.1 and 9.1 of the B]
[JD.com Announces Financing Agreements for JD Logistics February 14, 2018, BEIJING JD.com, Inc. (NASDAQ:JD), Chinas largest retailer, today announced that it has entered into definitive agreements for the financing for its logistics subsidiary, JD Logistics, with investors including Hillhouse Capi]
[CUSIP No. 15911M107 13G Page x of x Pages 1. NAMES OF REPORTING PERSONS 2.]
[1 Name of Reporting Person Caledonia (Private) Investments Pty Limited IRS Identification No. of Above Person (EIN 98-1372936) 2 Check the Appropriate Box if a member of a Group (a) |_| (b) |_| 3 SEC USE ONLY 4 Citizenship or Place of Organization Australia NUMBER OF SHARES BENEFICIALLY OWNED BY EAC]
[Sylebra HK Company Limited I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY) 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [ ] 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Sylebra HK Company Limited is organized in Hong Kong NUMBER OF SHARES BENEFICIALLY OWNED BY EA]
[China Jo-Jo Drugstores Reports Third Quarter 2018 Financial Results HANGZHOU, China, February 14, 2018 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ:CJJD) (“Jo-Jo Drugstores" or the “Company”), a leading online and offline retailer and wholesale distributor of pharmaceutical and other healthc]
[Dang Yu (George) Pan 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP ¨ (a) ¨ (b) 3 SEC USE ONLY 4 SOURCE OF FUNDS PF 5 o 6 CITIZENSHIP OR PLACE OF ORGANIZATION People's Republic of China NUMBER OF SHARES BENEFICIALLY OWNED BY]
[Weibo Reports Fourth Quarter and Fiscal Year 2017 Unaudited Financial Results BEIJING, China February 13, 2018 Weibo Corporation (Weibo or the Company) (NASDAQ: WB), a leading social media in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended ]
[SCHEDULE 13G/A Amendment No. 13 China Cord Blood Corporation (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 698659109 (CUSIP Number) December 31, 2017 (Date of Event Which Requires Filing of this Statement) ☐ Rule 13d-1(b) ☒ Rule 13d-1(c) ☐ Rule 13d-1(d) *T]
